Treatment for liver metastases typically aims to alleviate symptoms and increase life expectancy. In most cases, there is no way to cure liver metastases.

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Yttrium-90 resin microspheres selective internal radiation therapy (90Y-SIRT) is a potent treatment for patients with liver metastases due to gastrointestinal stromal tumors (GIST) resistant to TKI ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.

The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy, to be made available on the NHS.